The utility of IMP3 immunohistochemical staining in differentiating nodular lymphocyte predominant Hodgkin Lymphoma from T-Cell/Histiocyte-Rich large B-Cell lymphoma.

Kosari, Farid; Bakhshi, Trifeh; Ameli, Fereshteh; Mokhtari, Maral

Kosari, Farid; Bakhshi, Trifeh; Ameli, Fereshteh; Mokhtari, Maral.

Afiliación

Kosari F; Fellowship of Hematopathology, Department of Pathology, Shariati Hospital, Tehran University of Medical Science, Tehran, Iran.
Bakhshi T; Department of Pathology, Cancer Institute Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran.
Ameli F; Department of Pathology, Cancer Institute Imam Khomeini Hospital Complex, Tehran University of Medical Science, Tehran, Iran. f-ameli@sina.tums.ac.ir.
Mokhtari M; Fellowship of Hematopathology, Shiraz University of Medical Science, Shiraz, Iran.

BMC Cancer ; 22(1): 1359, 2022 Dec 28.

Article en En | MEDLINE | ID: mdl-36577979

Asunto(s)

Enfermedad de Hodgkin; Linfoma de Células B Grandes Difuso; Humanos; Masculino; Femenino; Adulto; Persona de Mediana Edad; Adolescente; Adulto Joven; Enfermedad de Hodgkin/patología; Histiocitos/metabolismo; Histiocitos/patología; Estudios Retrospectivos; Linfoma de Células B Grandes Difuso/patología; Linfocitos/patología; Linfocitos T/metabolismo

Palabras clave

Nodular lymphocyte predominant Hodgkin lymphoma, T cell/histiocyte-rich large B-cell lymphoma, IMP3, Immunohistochemistry

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Enfermedad de Hodgkin / Linfoma de Células B Grandes Difuso Tipo de estudio: Observational_studies Límite: Adolescent / Adult / Female / Humans / Male / Middle aged Idioma: En Revista: BMC Cancer Asunto de la revista: NEOPLASIAS Año: 2022 Tipo del documento: Article País de afiliación: Irán

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google